Synthesis, biological evaluation and molecular docking studies of novel benzimidazole derivatives

A novel series of N-substituted-benzimidazolyl linked para substituted benzylidene based molecules containing three pharmacologically potent hydrogen bonding parts namely; 2,4-thiazolidinedione (TZD: a 2,4-dicarbonyl), diethyl malonate (DEM: a 1,3-diester and an isooxazolidinedione analog) and methyl acetoacetate (MAA: a β-ketoester) (6a-11b) were synthesized and evaluated for in vitro α-glucosidase inhibition. The structure of the novel synthesized compounds was confirmed through the spectral studies (LC-MS, 1H NMR, 13C NMR, FT-IR). Comparative evaluation of these compounds revealed that the compound 9b showed maximum inhibitory potential against α-amylase and α-glucosidase giving an IC50 value of 0.54 ± 0.01 μM. Furthermore, binding affinities in terms of G score values and hydrogen bond interactions between all the synthesized compounds and the AA residues in the active site of the protein (PDB code: 3TOP) to that of Acarbose (standard drug) were explored with the help of molecular docking studies. Compound 9b was considered as promising candidate of this series.

[1]  P. Montgomery,et al.  Acarbose: an alpha-glucosidase inhibitor. , 1996, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[2]  M. Rashidi,et al.  Design, synthesis, α-glucosidase inhibitory activity, molecular docking and QSAR studies of benzimidazole derivatives , 2016 .

[3]  I. West.  Radicals and oxidative stress in diabetes , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[4]  3D-QSAR study of tyrosine and propanoic acid derivatives as PPARα/γ dual agonists using CoMSIA , 2012, Medicinal Chemistry Research.

[5]  A. Kuhad,et al.  Novel indole-2-carboxylic acid linked 3-phenyl-2-alkoxy propanoic acids: Synthesis, molecular docking and in vivo antidiabetic studies , 2017, Medicinal Chemistry Research.

[6]  S. Mehdi,et al.  Therapeutic evolution of benzimidazole derivatives in the last quinquennial period. , 2017, European journal of medicinal chemistry.

[7]  R. Chakrabarti,et al.  Diabetes and insulin resistance associated disorders: Disease and the therapy , 2002 .

[8]  Amanjot Singh,et al.  Indolyl linked meta-substituted benzylidene-based novel PPAR ligands: synthetic and docking studies , 2015, Medicinal Chemistry Research.

[9]  V. Kumar,et al.  Design and Synthesis of Benzimidazole-Linked meta-Substituted Benzylidenes/Benzyls as Biologically Significant New Chemical Entities , 2013 .

[10]  S. S. Azam,et al.  Benzimidazole derivatives as new α-glucosidase inhibitors and in silico studies. , 2016, Bioorganic chemistry.

[11]  A. Asiri,et al.  Synthesis of novel indenoquinoxaline derivatives as potent α-glucosidase inhibitors. , 2014, Bioorganic & medicinal chemistry.

[12]  I. Björck,et al.  An in vitro procedure based on chewing to predict metabolic response to starch in cereal and legume products. , 1992, European journal of clinical nutrition.

[13]  M. Özil,et al.  A simple and efficient synthesis of novel inhibitors of alpha-glucosidase based on benzimidazole skeleton and molecular docking studies. , 2016, Bioorganic chemistry.

[14]  V. Kumar,et al.  Design, synthesis and computational validation of novel benzimidazole/indole-based PPARα and PPARγ partial agonists , 2013, Journal of Chemical Sciences.

[15]  A. Rehman,et al.  Synthesis, α-glucosidase inhibitory, cytotoxicity and docking studies of 2-aryl-7-methylbenzimidazoles. , 2016, Bioorganic chemistry.

[16]  The application of comparative molecular field analysis for the design of α-anilino substituted-3-phenyl propanoic acids as novel PPARα/γ dual ligands , 2012, Medicinal Chemistry Research.

[17]  A. Tiwari,et al.  Synthesis, biological evaluation and molecular modeling studies of some novel thiazolidinediones with triazole ring. , 2013, European journal of medicinal chemistry.